These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs. Shin MK, Kang ML, Jung MH, Cha SB, Lee WJ, Kim JM, Kim DH, Yoo HS. Vet Immunol Immunopathol; 2013 Jan 15; 151(1-2):132-9. PubMed ID: 23206402 [Abstract] [Full Text] [Related]
8. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals. Liu J, Chen X, Lin L, Tan C, Chen Y, Guo Y, Jin M, Guo A, Bei W, Chen H. Vaccine; 2007 Nov 01; 25(44):7696-705. PubMed ID: 17767980 [Abstract] [Full Text] [Related]
12. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA]. Liu J, Chen Y, Hu L, Bei W, Chen H. Sheng Wu Gong Cheng Xue Bao; 2010 Mar 01; 26(3):305-10. PubMed ID: 20518341 [Abstract] [Full Text] [Related]
14. Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model. Seo KW, Kim SH, Park J, Son Y, Yoo HS, Lee KY, Jang YS. Vet Immunol Immunopathol; 2013 Jan 15; 151(1-2):102-12. PubMed ID: 23200821 [Abstract] [Full Text] [Related]
15. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae. Inzana TJ, Glindemann G, Fenwick B, Longstreth J, Ward D. Vet Microbiol; 2004 Nov 30; 104(1-2):63-71. PubMed ID: 15530740 [Abstract] [Full Text] [Related]